Publications by authors named "Richard L Price"

Article Synopsis
  • The Mobi-C Cervical Disc Replacement is FDA-approved for treating multiple levels of the cervical spine and is shown to be effective compared to traditional fusion surgery based on clinical trial data.
  • The article reviews the history, biomechanics, clinical results, long-term outcomes, and cost-effectiveness of Mobi-C, indicating it is a strong alternative to fusion.
  • Expert opinion highlights Mobi-C's proven track record, suggesting it preserves motion, provides positive clinical outcomes, and ensures patient safety, making it a favorable option for appropriate candidates.
View Article and Find Full Text PDF

Background And Objective: In our outpatient pediatric and adult psychiatry centers, we reserve psychostimulants for predominantly inattentive attention deficit hyperactivity disorder (ADHD) due to the potential for appetite and growth suppression, insomnia, wear off, exacerbation of mood, anxiety, and tics, or misuse. We utilize extended-release (ER) alpha-2 agonists primarily for hyperactivity/impulsivity but find them less effective for inattention, and they can cause sedation and hypotension. Oftentimes, we need to combine an alpha-2 agonist for behavior with psychostimulants for inattention.

View Article and Find Full Text PDF

Objective: To critically analyze the evidence and efficacy of cannabis to treat surgical and nonsurgical back pain via a Systematic Review.

Methods: We conducted a systematic review to investigate the efficacy of cannabis to treat non-surgical and surgical back pain. A literature search was performed with MEDLINE and Embase databases.

View Article and Find Full Text PDF

Cervical total disc replacement (CTDR) has gained popularity over the last 2 decades. It is a motion-preserving option to ACDF and is becoming more popular with patients and surgeons alike. Understanding complications that are unique to CTDR is crucial to performing successful, durable surgery.

View Article and Find Full Text PDF

Purpose: Glioblastoma (GBM) is one of the deadliest cancers with no cure. While conventional MRI has been widely adopted to examine GBM clinically, accurate neuroimaging assessment of tumor histopathology for improved diagnosis, surgical planning, and treatment evaluation remains an unmet need in the clinical management of GBMs.

Experimental Design: We employ a novel diffusion histology imaging (DHI) approach, combining diffusion basis spectrum imaging (DBSI) and machine learning, to detect, differentiate, and quantify areas of high cellularity, tumor necrosis, and tumor infiltration in GBM.

View Article and Find Full Text PDF

The authors describe 2 cases of triventricular hydrocephalus initially presenting as aqueductal stenosis that subsequently developed tumors of the pineal and tectal region. The first case resembled late-onset idiopathic aqueductal stenosis on serial imaging. Subsequent imaging revealed a new tumor in the pineal region causing mass effect on the midbrain.

View Article and Find Full Text PDF

Alveolar soft part sarcoma (ASPS) is an exquisitely rare sarcoma of unknown histogenesis, with a predilection for adolescents and young adults, characterized by slow progressive clinical course and high frequency of metastases. They are traditionally chemoresistant with very limited treatment options in the metastatic setting. Human cytomegalovirus (HCMV) is a DNA β-herpes virus and it is characterized by persistent lifelong and latent infection.

View Article and Find Full Text PDF

The hypothesis that cytomegalovirus (CMV) modulates cancer is evolving. Originally discovered in glioblastoma in 2002, the number of cancers, where intratumoral CMV antigen is detected, has increased in recent years suggesting that CMV actively affects the pathobiology of certain tumors. These findings are controversial as several groups have also reported inability to replicate these results.

View Article and Find Full Text PDF

Over the last decade, cytomegalovirus (CMV) has been suggested to promote the development of glioblastoma multiforme (GBM). Recent evidence demonstrates that CMV contributes to the progression of GBM in the context of oncosuppressor gene mutations. This finding provides further insights into the mechanisms whereby CMV exacerbates the malignancy of GBM.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the impact of cytomegalovirus (CMV) on glioblastoma using a genetically modified mouse model, highlighting early viral replication and inflammation in the brain.
  • During the initial weeks post-infection, a significant presence of CMV was observed in immune cells, but by seven weeks, viral levels decreased, and infected mice had a shorter survival rate due to their brain tumors compared to controls.
  • The research also links CMV infection to increased levels of phosphorylated STAT3 in neural stem cells, suggesting that both murine and human CMV may promote tumor growth through a STAT3-dependent mechanism, potentially influencing glioma development in both mice and humans.
View Article and Find Full Text PDF

Cytomegalovirus (CMV) has been detected in several human cancers, but it has not proven to be oncogenic. However, recent studies have suggested mechanisms through which cytomegalovirus may modulate the tumor environment, encouraging its study as a positive modifier of tumorigenesis. In this study, we investigated the effects of cytomegalovirus infection in Trp53 heterozygous mice.

View Article and Find Full Text PDF